News Center
March 18, 2025
Improving Clinical Diagnostics of Repeat Expansion Disorders with Combined Short and Long-Read WGS
See how our use of combined short and long-read WGS is improving diagnostic performance of testing for neurological disorders caused by repeat expansions.
October 15, 2024
Variantyx Combines Long and Short Reads for Rare Disease Whole-Genome Diagnostic Test
- By Variantyx
- Posted in General Company Updates
GenomeWeb recently wrote a profile on Genomic Unity 2.0® – the first commercially available test to incorporate third-generation long-read Oxford...
September 18, 2024
Variantyx Brings the First Combined Short- and Long-Read Whole Genome Sequencing Test to Market with Genomic Unity® 2.0
- By Variantyx
- Posted in General Company Updates
FRAMINGHAM, Mass. September 18, 2024 (Business Wire) – Variantyx, a leading molecular diagnostics lab, today announced the launch of Genomic...
May 21, 2024
Longer ZFHX3 repeat lengths correlate with earlier age of onset of SCA4
- By Variantyx
- Posted in Repeat Expansions
For years scientists believed they knew where the causal gene for spinocerebellar ataxia (SCA4) could be found, but the identity...
April 26, 2024
Variantyx Secures $36M Investment As Testing Demand And Market Share Continues To Increase
- By Variantyx
- Posted in General Company Updates
FRAMINGHAM, Mass. April 26, 2024 (Business Wire) – Variantyx, a leader in molecular diagnostics, announced today that it has secured...
November 30, 2023
Expanded STR Detection Capability Enables Variantyx to Diagnose Additional Genetic Disorders
- By Variantyx
- Posted in General Company Updates
FRAMINGHAM, Mass. November 30, 2023 (PRNewswire) – Variantyx, a leader in genomic precision medicine, today announced that the set of...
November 10, 2023
Variantyx Expands Its Reproductive Health Offerings with Launch of a Direct Replacement for Chromosomal Microarray Analysis
- By Variantyx
- Posted in General Company Updates
FRAMINGHAM, Mass. November 10, 2023 (PRNewswire) – Variantyx, a leader in genomic precision medicine, today announced the launch of its...
October 18, 2023
Variantyx Announces Additional Investment Enabling Rapid Expansion of Its Commercial Footprint
- By Variantyx
- Posted in General Company Updates
FRAMINGHAM, Mass. October 18, 2023 (PRNewswire) – Variantyx, a leader in genomic precision medicine today, announced that it has secured...
July 28, 2023
PGx testing informs clinical management for cancer patients
- By Variantyx
- Posted in Clinical Education
Somatic testing of solid tumors has become the standard of care. Specific mutations in genes such as BRAF, EGFR, NTRK...
July 7, 2023
Company Spotlight Series: Greice Krautz-Peterson
- By Variantyx
- Posted in Company Spotlight Series
Meet Greice, Associate Director of Germline Assay Development at Variantyx! This inspired me to get an MS and PhD in...